Table 1.
Trial\Drug | CBZ | PHB | PHT | VPS | LTG | OXC | LEV | TPM | GBP | ZNS | Total |
Total randomiseda |
Trials providing individual participant data | ||||||||||||
Banu 2007 | 54 | 54 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 108 | 108 |
Baulac 2012 | 301 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 282 | 583 | 583 |
Bill 1997 | 0 | 0 | 144 | 0 | 0 | 143 | 0 | 0 | 0 | 0 | 287 | 287 |
Biton 2001 | 0 | 0 | 0 | 69 | 66 | 0 | 0 | 0 | 0 | 0 | 135 | 136 |
Brodie 1995a | 66 | 0 | 0 | 0 | 70 | 0 | 0 | 0 | 0 | 0 | 136 | 136 |
Brodie 1995b | 63 | 0 | 0 | 0 | 61 | 0 | 0 | 0 | 0 | 0 | 124 | 124 |
Brodie 1999 | 48 | 0 | 0 | 0 | 102 | 0 | 0 | 0 | 0 | 0 | 150 | 150 |
Brodie 2007 | 291 | 0 | 0 | 0 | 0 | 0 | 288 | 0 | 0 | 0 | 579 | 579 |
Chadwick 1998 | 74 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 218 | 0 | 292 | 292 |
Craig 1994 | 0 | 0 | 81 | 85 | 0 | 0 | 0 | 0 | 0 | 0 | 166 | 166 |
de Silva 1996 | 54 | 10 | 54 | 49 | 0 | 0 | 0 | 0 | 0 | 0 | 167 | 173 |
Dizdarer 2000 | 26 | 0 | 0 | 0 | 0 | 26 | 0 | 0 | 0 | 0 | 52 | 52 |
Eun 2012 | 41 | 0 | 0 | 0 | 43 | 0 | 0 | 0 | 0 | 0 | 84 | 84 |
Guerreiro 1997 | 0 | 0 | 94 | 0 | 0 | 99 | 0 | 0 | 0 | 0 | 193 | 193 |
Heller 1995 | 61 | 58 | 63 | 61 | 0 | 0 | 0 | 0 | 0 | 0 | 243 | 243 |
Kwan 2009 | 0 | 0 | 0 | 44 | 37 | 0 | 0 | 0 | 0 | 0 | 81 | 81 |
Lee 2011 | 53 | 0 | 0 | 0 | 57 | 0 | 0 | 0 | 0 | 0 | 110 | 110 |
Mattson 1985 | 155 | 155 | 165 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 475 | 475 |
Mattson 1992 | 236 | 0 | 0 | 244 | 0 | 0 | 0 | 0 | 0 | 0 | 480 | 480 |
Nieto‐Barrera 2001 | 202 | 0 | 0 | 0 | 420 | 0 | 0 | 0 | 0 | 0 | 622 | 622 |
Ogunrin 2005 | 19 | 18 | 18 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 55 | 55 |
Pal 1998 | 0 | 47 | 47 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 94 | 94 |
Placencia 1993 | 95 | 97 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 192 | 192 |
Privitera 2003 (CBZ branch)b | 129 | 0 | 0 | 0 | 0 | 0 | 0 | 266 | 0 | 0 | 395 | 395 |
Privitera 2003 (VPS branch)b | 0 | 0 | 0 | 78 | 0 | 0 | 0 | 147 | 0 | 0 | 225 | 225 |
Ramsey 1992 | 0 | 0 | 50 | 86 | 0 | 0 | 0 | 0 | 0 | 0 | 136 | 136 |
Ramsey 2010 | 0 | 0 | 128 | 0 | 0 | 0 | 0 | 133 | 0 | 0 | 261 | 261 |
Reunanen 1996 | 121 | 0 | 0 | 0 | 230 | 0 | 0 | 0 | 0 | 0 | 351 | 351 |
Richens 1994 | 151 | 0 | 0 | 149 | 0 | 0 | 0 | 0 | 0 | 0 | 300 | 300 |
SANAD A 2007 | 378 | 0 | 0 | 0 | 378 | 210 | 0 | 378 | 377 | 0 | 1721 | 1721 |
SANAD B 2007 | 0 | 0 | 0 | 238 | 239 | 0 | 0 | 239 | 0 | 0 | 716 | 716 |
Steiner 1999 | 0 | 0 | 95 | 0 | 86 | 0 | 0 | 0 | 0 | 0 | 181 | 181 |
Stephen 2007 | 0 | 0 | 0 | 109 | 117 | 0 | 0 | 0 | 0 | 0 | 226 | 227 |
Trinka 2013 (CBZ branch)b | 503 | 0 | 0 | 0 | 0 | 0 | 493 | 0 | 0 | 0 | 996 | 999 |
Trinka 2013 (VPS branch)b | 0 | 0 | 0 | 353 | 0 | 0 | 350 | 0 | 0 | 0 | 703 | 703 |
Turnbull 1985 | 0 | 0 | 70 | 70 | 0 | 0 | 0 | 0 | 0 | 0 | 140 | 140 |
Verity 1995 | 130 | 0 | 0 | 130 | 0 | 0 | 0 | 0 | 0 | 0 | 260 | 260 |
Werhahn 2015 | 121 | 0 | 0 | 0 | 118 | 0 | 122 | 0 | 0 | 0 | 361 | 361 |
Total | 3372 | 439 | 1009 | 1765 | 2024 | 478 | 1253 | 1163 | 595 | 282 | 12,380 | 12,391 |
Trials not providing individual participant data | ||||||||||||
Trial\Drug | CBZ | PHB | PHT | VPS | LTG | OXC | LEV | TPM | GBP | ZNS | Total |
Total randomiseda |
Aikia 1992 | 0 | 0 | 18 | 0 | 0 | 19 | 0 | 0 | 0 | 0 | 37 | 37 |
Bidabadi 2009 | 36 | 35 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 71 | 71 |
Brodie 2002 | 0 | 0 | 0 | 0 | 151 | 0 | 0 | 0 | 158 | 0 | 309 | 309 |
Callaghan 1985 | 59 | 0 | 58 | 64 | 0 | 0 | 0 | 0 | 0 | 0 | 181 | 181 |
Capone 2008 | 17 | 0 | 0 | 0 | 0 | 0 | 18 | 0 | 0 | 0 | 35 | 35 |
Castriota 2008 | 14 | 0 | 0 | 0 | 0 | 0 | 13 | 0 | 0 | 0 | 27 | 27 |
Chen 1996 | 26 | 25 | 0 | 25 | 0 | 0 | 0 | 0 | 0 | 0 | 76 | 76 |
Cho 2011 | 15 | 0 | 0 | 0 | 0 | 0 | 16 | 0 | 0 | 0 | 31 | 31 |
Christe 1997 | 0 | 0 | 0 | 121 | 0 | 128 | 0 | 0 | 0 | 0 | 249 | 249 |
Consoli 2012 | 66 | 0 | 0 | 0 | 0 | 0 | 62 | 0 | 0 | 0 | 128 | 128 |
Cossu 1984 | 6 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12 | 12 |
Czapinski 1997 | 30 | 30 | 30 | 30 | 0 | 0 | 0 | 0 | 0 | 0 | 120 | 120 |
Dam 1989 | 100 | 0 | 0 | 0 | 0 | 94 | 0 | 0 | 0 | 0 | 194 | 194 |
Donati 2007 | 28 | 0 | 0 | 29 | 0 | 55 | 0 | 0 | 0 | 0 | 112 | 112 |
Feksi 1991 | 152 | 150 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 302 | 302 |
Forsythe 1991 | 23 | 0 | 20 | 21 | 0 | 0 | 0 | 0 | 0 | 0 | 64 | 64 |
Fritz 2006 | 0 | 0 | 0 | 0 | 21 | 27 | 0 | 0 | 0 | 0 | 48 | 48 |
Gilad 2007 | 32 | 0 | 0 | 0 | 32 | 0 | 0 | 0 | 0 | 0 | 64 | 64 |
Jung 2015 | 64 | 0 | 0 | 0 | 0 | 0 | 57 | 0 | 0 | 0 | 121 | 121 |
Kalviainen 2002 | 70 | 0 | 0 | 0 | 73 | 0 | 0 | 0 | 0 | 0 | 143 | 143 |
Kopp 2007 | 6 | 0 | 0 | 3 | 0 | 0 | 6 | 0 | 0 | 0 | 15 | 15 |
Korean Lamotrigine Study Group 2008 | 129 | 0 | 0 | 0 | 264 | 0 | 0 | 0 | 0 | 0 | 393 | 393 |
Lukic 2005 | 0 | 0 | 0 | 38 | 35 | 0 | 0 | 0 | 0 | 0 | 73 | 73 |
Mitchell 1987 | 15 | 18 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 33 | 33 |
Miura 1990 | 66 | 0 | 51 | 46 | 0 | 0 | 0 | 0 | 0 | 0 | 163 | 163 |
Motamedi 2013 | 0 | 0 | 0 | 0 | 50 | 0 | 50 | 0 | 0 | 0 | 100 | 100 |
NCT01498822 | 0 | 0 | 0 | 0 | 0 | 178 | 175 | 0 | 0 | 0 | 353 | 353 |
NCT01954121 | 215 | 0 | 0 | 0 | 0 | 0 | 218 | 0 | 0 | 0 | 433 | 433 |
Pulliainen 1994 | 23 | 0 | 20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 43 | 43 |
Ramsey 1983 | 42 | 0 | 45 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 87 | 87 |
Ramsey 2007c | ? | 0 | 0 | 0 | 0 | 0 | ? | 0 | 0 | 0 | 37 | 37 |
Rastogi 1991 | 0 | 0 | 45 | 49 | 0 | 0 | 0 | 0 | 0 | 0 | 94 | 94 |
Ravi Sudhir 1995 | 20 | 0 | 20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40 | 40 |
Resendiz 2004 | 42 | 0 | 0 | 0 | 0 | 0 | 0 | 46 | 0 | 0 | 88 | 88 |
Rowan 2005 | 198 | 0 | 0 | 0 | 200 | 0 | 0 | 0 | 195 | 0 | 593 | 593 |
Saetre 2007 | 92 | 0 | 0 | 0 | 93 | 0 | 0 | 0 | 0 | 0 | 185 | 185 |
Shakir 1981 | 0 | 0 | 15 | 18 | 0 | 0 | 0 | 0 | 0 | 0 | 33 | 33 |
So 1992 | 17 | 0 | 0 | 16 | 0 | 0 | 0 | 0 | 0 | 0 | 33 | 33 |
Suresh 2015 | 30 | 0 | 0 | 0 | 0 | 0 | 30 | 0 | 0 | 0 | 60 | 60 |
Steinhoff 2005 | 88 | 0 | 0 | 30 | 121 | 0 | 0 | 0 | 0 | 0 | 239 | 239 |
Thilothammal 1996 | 0 | 51 | 52 | 48 | 0 | 0 | 0 | 0 | 0 | 0 | 151 | 151 |
Totalc | 1721 | 315 | 374 | 538 | 1040 | 501 | 645 | 46 | 353 | 0 | 5570 | 5570 |
Grand totalc | 5093 | 754 | 1383 | 2303 | 3064 | 979 | 1898 | 1209 | 948 | 282 | 17,950 | 17,961 |
CBZ: carbamazepine; GBP: gabapentin; IPD: individual participant data; ITT: intention to treat; LEV: levetiracetam; LTG: lamotrigine; OXC: oxcarbazepine; PHB: phenobarbitone; PHT: phenytoin; TPM: topiramate; VPS: sodium valproate; ZNS: zonisamide
aDrug allocated missing for 11 participants in the IPD provided. bTrials designed in two strata based on whether recommended treatment would be CBZ or VPS. Within the two strata, participants were randomised to TPM in Privitera 2003/LEV in Trinka 2013 or CBZ/VPS depending on the strata. Data analysed according to the separate strata (CBZ branch or VPS branch) in this review. cOne trial provided the total number randomised but not the numbers randomised to each group. The 37 participants randomised are counted in the overall totals.